Isaac Francis

Australian Clinical Labs (ASX:ACL) appointed Greg Horan as its new Group CEO and executive director.

The US cryptocurrency industry is increasingly backing Republican political candidates ahead of the midterm elections as crypto-linked super PACs expand their influence across congressional races.

NoviqTech's (ASX:NVQ) subsidiary Coralia has commenced its field and pyrolysis trial at its flagship Great Barrier Reef Biochar Project.

Alpha Compute (NYSE:ALP) closed its previously announced majority acquisition of gaming and digital rewards platform GAMEE, expanding its footprint into digital consumer applications and establishing a newly formed business division called Alpha Games.

Biohaven (NYSE:BHVN) reported positive preliminary clinical data from its ongoing Phase 1b trials evaluating two novel extracellular protein degraders, hitting key biological markers and clearing a path toward advanced clinical development.

Dycom Industries (NYSE:DY) reported record financial results for its fiscal first quarter of 2027, driven by strong demand for digital infrastructure deployments.

Apogee Therapeutics (NASDAQ:APGE) reported positive mid-stage clinical data for its experimental eczema treatment, paving the way for late-stage trials later this year alongside a new multi-indication financing deal with Blackstone Life Sciences.

Bank of Montreal (NYSE:BMO) has released its financial results for the second quarter of 2026, posting a reported net income of $2.63 billion.

Silvercorp Metals (NYSE:SVM reported record revenue for its full fiscal year 2026, driven by a dramatic rally in global silver prices that generated substantial operating cash flow and offset heavy non-cash accounting adjustments.

Cryosite (ASX:CTE) has delivered a strong financial performance for the ten months to April 30.